Readers question Robert F. Kennedy Jr. and advocate research on HIV prevention and microplastics.

That's the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that ...

A post on Facebook claims that a new cure for Acquired immunodeficiency syndrome (AIDS) has been discovered and will cost $40 ...

Gilead's once-yearly injectable lenacapavir shows promising results in HIV prevention, with a 96% reduction in infections and plans for regulatory filings by 2027.

"PrEP reduces the risk of getting HIV from sex by about 99 percent when taken as prescribed. Although there is less ...

The development of the HIV infection-preventing drug lenacapavir is the most important research development of 2024, Science ...

Deaths from HIV/AIDS are ten times lower than at the peak of the epidemic, and new research could drive that down even more.

Gilead Sciences’ top money maker Biktarvy has been the company’s crown jewel for years now, but with the HIV med inching ...

The New York State Department of Health AIDS Institute wrapped up its Ending the Epidemic Summit and World AIDS Day events at the Albany Capital Center.

A qualitative study spoke to emergency department and HIV clinic staff to evaluate the feasibility of initiating pre-exposure ...

A drug used to treat HIV that has also shown promise in preventing infections is not a cure for those already infected, as ...

Considerable scale-up is needed to achieve the 2025 goals for HIV pre-exposure prophylaxis (PrEP), according to study findings.